NEW YORK (GenomeWeb) – The University of Manchester today said that it has been awarded £24 million ($38.5 million), including funding for omics-directed projects, from the UK government.

The University of Manchester is getting about £13 million to create a Clinical Proteomics Centre, where researchers will aim to differentiate healthy patients from those with disease in order to provide treatment at an earlier disease stage and gain insight into patient response to specific drugs. The university noted research could be directed at psoriasis, rheumatoid arthritis, and cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.